Glucose Health Statistics
Total Valuation
Glucose Health has a market cap or net worth of 1.57 million.
| Market Cap | 1.57M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Glucose Health has 17.41 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 17.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.41 |
| PB Ratio | 2.02 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 534.12
| Current Ratio | 534.12 |
| Quick Ratio | 312.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -45.79% |
| Revenue Per Employee | 370,900 |
| Profits Per Employee | -119,010 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.00% in the last 52 weeks. The beta is 3.72, so Glucose Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.72 |
| 52-Week Price Change | -82.00% |
| 50-Day Moving Average | 0.10 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 45.77 |
| Average Volume (20 Days) | 3,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, Glucose Health had revenue of 1.11 million and -357,029 in losses. Loss per share was -0.03.
| Revenue | 1.11M |
| Gross Profit | 112,624 |
| Operating Income | -355,973 |
| Pretax Income | -355,973 |
| Net Income | -357,029 |
| EBITDA | n/a |
| EBIT | -355,973 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 308,536 in cash and n/a in debt, giving a net cash position of 308,536 or 0.02 per share.
| Cash & Cash Equivalents | 308,536 |
| Total Debt | n/a |
| Net Cash | 308,536 |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 777,392 |
| Book Value Per Share | 0.06 |
| Working Capital | 774,097 |
Cash Flow
| Operating Cash Flow | -350,436 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 10.12%, with operating and profit margins of -31.99% and -31.99%.
| Gross Margin | 10.12% |
| Operating Margin | -31.99% |
| Pretax Margin | -31.99% |
| Profit Margin | -31.99% |
| EBITDA Margin | n/a |
| EBIT Margin | -31.99% |
| FCF Margin | n/a |
Dividends & Yields
Glucose Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.79% |
| Shareholder Yield | -20.79% |
| Earnings Yield | -22.76% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 17, 2014. It was a reverse split with a ratio of 0.02.
| Last Split Date | Nov 17, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |